Department of Urology, Shanghai Jiaotong University School of Medicine, Shanghai, PR China
Cytotherapy. 2012 Nov;14(10):1215-27. doi: 10.3109/14653249.2012.711471. Epub 2012 Aug 27.
The effects of human Wharton's jelly-derived mesenchymal stromal cells (WJ-MSC) on acute and chronic kidney injury induced by ischemia-reperfusion injury (IRI) were assessed.
WJ-MSC were injected intravenously immediately after solitary kidney ischemia for 45 min. Cells were labeled with 5-bromo-2'deoxy-uridine (BrdU) for tracing in vivo. At 48 h post-IRI, serum creatinine and blood urea nitrogen (BUN) were measured. Tubular cell proliferation and apoptosis as well as activation of the Akt signal were identified by immunostaining. Real-time polymerase chain reaction (PCR) was employed to determine gene expression of inflammation-related cytokines and hepatocyte growth factor (HGF). Levels of human HGF were assayed by enzyme-linked immunosorbant assay (ELISA). Twenty-two weeks later, renal fibrosis was assessed by Masson's tri-chrome staining, collagen content and α-smooth muscle actin (α-SMA) staining.
There was no sign of labeled cells residing in the damaged kidney. Acute renal dysfunction elicited by IRI was considerably improved by WJ-MSC, in parallel with a stronger proliferative response and less apoptotic events. Additionally, phosphoAkt staining in injured tubular cells was substantially intensified. Cell treatment also caused a remarkable up-regulation of kidney interleukin (IL)-10, heme oxygenase (HO)-1 and HGF expression. Human HGF was detected in cell supernatants and the serum of cell-infused rats. Moreover, IRI-initiated fibrosis was abrogated by cell therapy, coincident with function amelioration.
WJ-MSC alleviate acute kidney injury, thereby rescuing the ensuing fibrotic lesions in an endocrine manner. The Akt signal in impaired tubular cells is reinforced by WJ-MSC, facilitating cell resistance to apoptosis and cell proliferation. HGF, either delivered or induced by WJ-MSC, is an important contributor.
评估人沃顿氏胶来源间充质基质细胞(WJ-MSC)对缺血再灌注损伤(IRI)引起的急性和慢性肾损伤的影响。
在单肾缺血 45 分钟后立即静脉注射 WJ-MSC。用 5-溴-2'-脱氧尿苷(BrdU)标记细胞进行体内示踪。在 IRI 后 48 小时,测量血清肌酐和血尿素氮(BUN)。通过免疫染色鉴定肾小管细胞增殖和凋亡以及 Akt 信号的激活。实时聚合酶链反应(PCR)用于确定炎症相关细胞因子和肝细胞生长因子(HGF)的基因表达。通过酶联免疫吸附试验(ELISA)测定人 HGF 的水平。22 周后,通过 Masson 三色染色、胶原含量和α-平滑肌肌动蛋白(α-SMA)染色评估肾纤维化。
没有标记细胞在受损肾脏中存在的迹象。IRI 引起的急性肾功能障碍通过 WJ-MSC 得到显著改善,同时增殖反应增强,凋亡事件减少。此外,受损肾小管细胞中的磷酸化 Akt 染色明显增强。细胞治疗还导致肾脏白细胞介素(IL)-10、血红素加氧酶(HO)-1 和 HGF 的表达显著上调。在细胞上清液和细胞输注大鼠的血清中检测到人 HGF。此外,细胞治疗消除了 IRI 引发的纤维化,同时改善了肾功能。
WJ-MSC 减轻急性肾损伤,从而以内分泌方式挽救随后的纤维化病变。WJ-MSC 增强受损肾小管细胞中的 Akt 信号,促进细胞抵抗凋亡和增殖。HGF 无论是由 WJ-MSC 提供还是诱导,都是一个重要的贡献者。